Elimusertib is a pharmaceutical raw material and an ATR inhibitor under investigation in clinical trials for the research of relapsed or refractory solid tumors.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1876467-74-1
Tetrahydrouridine
pharmaceutical raw material
Derquantel
pharmaceutical raw material
Abacavir sulfate
pharmaceutical raw material
Temazepam acetate
pharmaceutical raw material
(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine
YBXRSCXGRPSTMW-CYBMUJFWSA-N
C[C@@H]1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C